LAURUSLABS Q2 FY27 Results Analysis: PAT Surges 126%, EBITDA Margin Beats Guidance
LAURUSLABS reported Q2 FY27 numbers with revenue of Rs. 2,206.37 Cr (+33.44% YoY) and PAT growth of +126.43% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | October 29, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Revenue (Q2) | Rs. 2,206.37 Cr (+33.44% YoY) |
| PAT (Q2) | Rs. 441.48 Cr (+126.43% YoY) |
| EBITDA margin | 34.01% (+962 bps YoY) |
| EPS (Q2) | Rs. 8.17 (+126.30% YoY) |
| Market cap | Rs. 121,076.81 Cr |
| CMP | Rs. 2,244.00 |
Quarter Snapshot
Q2 FY27 delivered a >400bps beat on the >30% EBITDA margin guidance at 34.01%, with revenue up 33.44% YoY and PAT to equity holders up 126.43% YoY on cost discipline (other expenses +0.82% YoY). Gross margin of 63.01% absorbed solvent cost inflation, and leverage softened to 1.03x even as H1 capex of Rs.864.19 Cr ran ahead of the Rs.3,000 Cr FY27-28 plan. Watch items are the inventory build (Rs.316.91 Cr H1 cash absorption) and CFO/EBITDA conversion at 0.58x during the capex phase.
Key Investment Insights
Key Positives
- Revenue grew 33.44% YoY to Rs.2,206.37 Cr (+8.89% QoQ)
- PAT to equity holders grew 126.43% YoY to Rs.441.48 Cr; basic EPS Rs.8.17 vs Rs.3.61
- EBITDA margin of 34.01% exceeded the >30% FY27 guidance by ~400bps and expanded ~962bps YoY
- Gross margin of 63.01% beat the 61.4% sustain guide despite solvent cost inflation
- Other expenses grew only 0.82% YoY against 33.44% revenue growth
- Net debt/LTM EBITDA softened to 1.03x from 1.28x while equity grew 13.80%
- H1 capex of Rs.864.19 Cr tracks ahead of the Rs.3,000 Cr FY27-28 plan; CWIP up 65.84%
- Interim dividend of Re 1.00/share declared; standalone ETR of 25.31% matched the 25% guide
Risk Factors
- Cost of materials grew 14.63% QoQ vs revenue +8.89% QoQ on petro-linked solvent/raw-material inflation
- Inventory build of Rs.129.61 Cr in Q2 (Rs.316.91 Cr H1 cash outflow) is a working-capital drawdown ahead
- FCF was negative at Rs.(59.23) Cr in H1 as capex nearly doubled to Rs.864.19 Cr
- CFO/EBITDA conversion fell to 0.58x from 1.39x in H1 FY26
- Q2 consolidated ETR of 26.20% sits at the top edge of the guided 25-26% band
- Non-controlling interests absorbed a Rs.(5.29) Cr quarterly loss (Rs.(10.82) Cr H1)
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.